Norihito Yoshida

Dr. Norihito Yoshida

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2025 in Nutrients
Verified
Journal Article
Open access
STSadamu Takahashi
Sadamu Takahashi
TTTatsuki Tanaka
Tatsuki Tanaka
YSYusuke Suzuki
Yusuke Suzuki
NYNorihito Yoshida
Norihito Yoshida
MHMai Hitaka
Mai Hitaka
YOYasushi Ohashi
Yasushi Ohashi
Background/Objectives: Malnutrition, muscle wasting, and fluid overload are highly prevalent in patients undergoing maintenance hemodialysis (HD) and may contribute to increased mortality risk. However, the combined impact of these factors has not been fully elucidated. Methods: In this multicenter prospective cohort study, we enrolled 368 patients in maintenance HD at four dialysis facilities in Japan. Malnutrition was defined as moderate or higher nutritional risk using the nutritional risk index for Japanese hemodialysis patients (NRI-JH). Low muscle mass was assessed using the skeletal muscle mass index (SMI) according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019), and elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) was defined as values in the top quartile (≥7650 pg/mL). Mortality risk was analyzed using Cox proportional hazards models. Associations with inflammation, assessed by C-reactive protein (CRP), were also explored. Results: Over a three-year follow-up period, 52 deaths occurred. Malnutrition, low muscle mass, and elevated NT-proBNP were each independently associated with increased all-cause mortality (HR: 4.98, 3.25, and 5.45, respectively). Patients with multiple concurrent risk factors had significantly worse survival. Although CRP was positively associated with these risk factors, it was not an independent predictor of mortality. Conclusions: Malnutrition, low muscle mass, and elevated NT-proBNP are independent and additive risk factors for mortality in HD patients. These findings highlight the need for integrated assessment and management strategies to improve prognoses in this high-risk population.

10 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NYNorihito Yoshida
Norihito Yoshida
TTTatsuki Tanaka
Tatsuki Tanaka
YSYusuke Suzuki
Yusuke Suzuki
STSadamu Takahashi
Sadamu Takahashi
MHMai Hitaka
Mai Hitaka
YOYasushi Ohashi
Yasushi Ohashi
Sleep disturbances are highly prevalent in hemodialysis (HD) patients and are associated with impaired quality of life (QOL) and poor outcomes. However, the independent impact of sleep quality on QOL and mortality in this population remains unclear. Methods: In this multicenter observational study, 346 HD patients completed the Kidney Disease Quality of Life–Short Form (KDQOL-SF). A composite sleep score was derived from sleep-related items, and patients were stratified into tertiles (Q1–Q3). Clinical characteristics, QOL outcomes, and survival were compared across tertiles. Associations between sleep quality and QOL domains were assessed using linear regression, while Cox proportional hazards models were applied to evaluate mortality risk. Results: Patients in the lowest tertile (Q1) consistently demonstrated significantly lower scores across multiple SF-36 and kidney-disease-specific QOL domains compared with Q2 and Q3 (all p < 0.001). Kaplan–Meier analysis showed lower cumulative survival in Q1 (log-rank p = 0.012). In Cox models, Q1 was associated with higher mortality compared to Q3 in both unadjusted (HR, 2.58; 95% CI, 1.46–4.54; p = 0.001) and adjusted models (Model 3: HR, 2.04; 95% CI, 1.11–3.77; p = 0.023). The associations between Q1 and Q2 were attenuated after full adjustment (HR, 1.88; 95% CI, 0.98–3.60; p = 0.058). Conclusions: Poor sleep quality was independently associated with impaired QOL and increased all-cause mortality in HD patients. These associations remained significant even after adjustment for inflammation and dialysis adequacy, suggesting that sleep quality reflects a distinct pathophysiological condition and may serve as an important, potentially modifiable indicator of patient well-being and prognosis.

21 November 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
NYNorihito Yoshida
Norihito Yoshida
TTTatsuki Tanaka
Tatsuki Tanaka
YSYusuke Suzuki
Yusuke Suzuki
STSadamu Takahashi
Sadamu Takahashi
MHMai Hitaka
Mai Hitaka
YOYasushi Ohashi
Yasushi Ohashi
Background/Objectives: The phase angle (PA), derived from bioelectrical impedance analysis (BIA), reflects cellular integrity and nutritional status. Previous studies have reported associations between PA, QOL, and prognosis in hemodialysis patients; however, evidence in Japanese populations remains limited. This multicenter study aimed to confirm and extend these associations by examining the relationships of PA with QOL domains and survival outcomes in maintenance HD patients. Methods: In this multicenter cross-sectional study, 319 HD patients were stratified into sex-specific PA quartiles, and baseline characteristics, laboratory data, and body composition measures were compared across groups. Health-related QOL was assessed using the SF-36 and KDQOL-SF™. Associations between PA and QOL were tested with multivariable linear regression models. Survival was evaluated using Kaplan–Meier analysis with Bonferroni-adjusted pairwise comparisons. Results: Higher PA was significantly associated with favorable nutritional and laboratory parameters, including higher hemoglobin, albumin, creatinine, and GNRI, and lower NT-proBNP. PA also correlated positively with muscle mass and intracellular water, and inversely with the ECW/ICW ratio. Multivariable analyses showed that PA remained independently associated with several physical QOL domains, including physical functioning, role—physical, and general health, even after adjustment for dialysis adequacy (Kt/V) and inflammation (CRP). Kaplan–Meier analysis demonstrated lower survival in the lowest PA quartile, and ROC analysis identified sex-specific cutoff values for predicting mortality (4.0° for females, 4.8° for males). Conclusions: This multicenter confirmatory study showed that PA is independently associated with nutritional status, physical QOL, and mortality in maintenance hemodialysis patients. PA may serve as a practical, noninvasive biomarker for nutritional and functional assessment in clinical practice.

20 November 2024 in American Journal of Case Reports
Verified
Journal Article
Open access
NYNorihito Yoshida
Norihito Yoshida
STSadamu Takahashi
Sadamu Takahashi
MHMai Hitaka
Mai Hitaka
YOYasushi Ohashi
Yasushi Ohashi
IRichibayashi ryo
ichibayashi ryo
Role of Renal Replacement Therapy in Managing Toluene-Induced Acidosis - Article abstract #945657

27 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NYNorihito Yoshida
Norihito Yoshida
TTTatsuki Tanaka
Tatsuki Tanaka
YSYusuke Suzuki
Yusuke Suzuki
STSadamu Takahashi
Sadamu Takahashi
MHMai Hitaka
Mai Hitaka
YOYasushi Ohashi
Yasushi Ohashi
Background/Objectives: Ankle–brachial index (ABI) is frequently measured in hemodialysis patients due to their high cardiovascular risk, while its potential role as a screening tool for assessing overall physical function and health-related quality of life (QOL) remains unclear. This study aimed to evaluate the association of the ABI with QOL and survival in hemodialysis patients. Methods: This study included 346 hemodialysis patients, categorized into two groups based on their ABI (≤0.9 vs. >0.9). Clinical parameters, QOL (measured using SF-36 and KDQOL questionnaires), and survival outcomes were analyzed. Results: There were 66 (19.1%) patients with an ABI ≤ 0.9 in this study population. Patients with an ABI ≤ 0.9 exhibited significantly older ages, longer dialysis durations, higher prevalence of diabetes mellites and cardiovascular disease, elevated N-terminal pro-brain natriuretic peptide levels, and higher calcitriol use but lower phase angle, skeletal muscle mass index values, health-related QOL domains, and several kidney disease-specific QOL domains compared to those with an ABI > 0.9. Kaplan–Meier analysis revealed significantly higher cumulative mortality in the ABI ≤ 0.9 group (6.6 vs. 2.5 per 100 patient-years, p < 0.001). Conclusions: A low ABI is significantly associated with decreased QOL and higher mortality risk in hemodialysis patients. While traditionally used for PAD screening, the ABI may serve as a practical tool for predicting QOL decline and survival outcomes. Interestingly, the ABI was also linked to muscle attenuation and volume overload. ABI assessment could aid in early risk stratification and guide multidisciplinary interventions, including exercise programs, nutritional support, and cardiovascular risk management, to improve patient care and outcomes.

3 February 2026 in Kidney360
Verified
Journal Article
Open access
SIShingo Ishii
Shingo Ishii
TTTatsuki Tanaka
Tatsuki Tanaka
YSYusuke Suzuki
Yusuke Suzuki
STSadamu Takahashi
Sadamu Takahashi
NYNorihito Yoshida
Norihito Yoshida
YOYasushi Ohashi
Yasushi Ohashi
Key Points: Both low skeletal muscle mass index and high extracellular and intracellular water independently predicted mortality; risk was highest when both abnormalities were present. Extracellular and intracellular water ≥0.66 indicated impaired muscle tissue integrity and helped identify vulnerable patients. Combining skeletal muscle mass index with extracellular and intracellular water identified patients with lower health-related quality of life across multiple domains. Background: Decreased skeletal muscle mass is common in hemodialysis patients and contributes to adverse outcomes. However, muscle mass alone does not fully capture muscle health. An imbalance between extracellular and intracellular water (ECW/ICW ratio) may reflect tissue-level integrity of skeletal muscle. This study examined the combined prognostic significance of the skeletal muscle mass index (SMI) and ECW/ICW ratio for mortality and health-related quality of life (HRQoL) in hemodialysis patients. Methods: In this multicenter cohort study, 295 maintenance hemodialysis patients (208 men, 87 women) underwent multifrequency bioelectrical impedance analysis. Low SMI was defined according to the Asian Working Group for Sarcopenia (men <7.0 kg/m 2 , women <5.7 kg/m 2 ), and high ECW/ICW was defined as ≥0.66. Patients were categorized into four groups based on SMI and ECW/ICW status. HRQoL was assessed using the Kidney Disease Quality of Life Short Form, and mortality was recorded through March 2024. Results: Among the cohort, 93 patients (31.5%) had low SMI and 38 (12.9%) had both low SMI and high ECW/ICW. These patients were older and demonstrated lower intracellular water, poorer nutritional status, chronic inflammation, and higher natriuretic peptide levels. During a median follow-up of 3.7 years, 34 patients died. Low SMI (hazard ratio [HR], 1.82; 95% confidence interval [CI], 1.11 to 3.65) and high ECW/ICW (HR, 2.21; 95% CI, 1.34 to 4.08) independently predicted mortality, while their coexistence conferred the highest risk (HR, 3.95; 95% CI 2.01 to 7.72). Both indices were associated with impaired HRQoL across multiple domains, particularly those related to physical functioning. Conclusions: Combined assessment of SMI and ECW/ICW identifies muscle vulnerability and predicts mortality and HRQoL in hemodialysis patients. This simple, noninvasive approach may improve early detection of high-risk individuals and inform targeted interventions addressing nutrition, inflammation, and fluid management.